Cite
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
MLA
10062416 - Kruger, Annamarie, et al. Use of Secondary Prevention Drugs for Cardiovascular Disease in the Community in High-Income, Middle-Income, and Low-Income Countries (the PURE Study): A Prospective Epidemiological Survey. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1263658021&authtype=sso&custid=ns315887.
APA
10062416 - Kruger, A., Avezum, A., Chow, C., Dagenais, G., Diaz, R., Gupta, R., Iqbal, R., Islam, S., Kelishadi, R., Kruger, A., Kutty, R., Lanas, F., Oguz, A., Rahman, O., Rangarajan, S., Rosengren, A., Swidan, H., Teo, K., Yusoff, K., … Lopez-Jaramillo, P. (2011). Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
Chicago
10062416 - Kruger, Annamarie, Alvaro Avezum, Clara Chow, Gilles Dagenais, Rafael Diaz, Rajeev Gupta, Romaina Iqbal, et al. 2011. “Use of Secondary Prevention Drugs for Cardiovascular Disease in the Community in High-Income, Middle-Income, and Low-Income Countries (the PURE Study): A Prospective Epidemiological Survey.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1263658021&authtype=sso&custid=ns315887.